Visualitza per autor "Rio Izquierdo, Jordi"
Ara mostrant els elements 1-4 d 4
-
Consensus on early detection of disease progression in patients with multiple sclerosis
Meca-Lallana, Jose Eustasio; Casanova, Bonaventura; Rodríguez-Antigüedad, Alfredo; Eichau-Madueño, Sara; Izquierdo, Guillermo; Durán, Carmen; Rio Izquierdo, Jordi (Frontiers Media, 2022-07-28) -
Immunotherapy for people with clinically isolated syndrome or relapsing-remitting multiple sclerosis: treatment response by demographic, clinical, and biomarker subgroups (PROMISE)—a systematic review protocol
Lehnert, Thomas; Röver, Christian; Köpke, Sascha; Rio Izquierdo, Jordi; Chard, Declan; Fittipaldo, Andrea Veronica (BMC, 2022-07-01) -
Oral contraceptives do not modify the risk of a second attack and disability accrual in a prospective cohort of women with a clinically isolated syndrome and early multiple sclerosis
Otero Romero, Susana; Carbonell-Mirabent, Pere; Midaglia Fernandez, Luciana; Zuluaga Rodas, Maria Isabel; Galán Cartaña, Ingrid; Cobo Calvo, Alvaro; Rio Izquierdo, Jordi; Arrambide García, Georgina; Vidal Jordana, Angela; Castillo Justribo, Joaquin; Rodriguez Acevedo, Breogan; Comabella Lopez, Manuel; Rodríguez Barranco, Marta; Tur Gomez, Carmen; Auger Acosta, Cristina; Rovira Cañellas, Alex; Sastre Garriga, Jaume; Montalban Gairín, Xavier; Tintore Subirana, Mar (SAGE Publications, 2022-05) -
Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab
Fissolo, Nicolás Miguel; Pignolet, Beatrice; Rio Izquierdo, Jordi; Vermersch, Patrick; Ruet, Aurélie; deSèze, Jerome; Montalban Gairín, Xavier; Comabella Lopez, Manuel (Lippincott Williams & Wilkins, 2021-07)